Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsBadr Al Bawardy, MD
Assistant Professor Adjunct of Medicine (Digestive Diseases)About
Copy Link
Titles
Assistant Professor Adjunct of Medicine (Digestive Diseases)
Biography
Badr Al Bawardy, MD, is a gastroenterologist at Yale Medicine specializing in inflammatory bowel disease (IBD), Crohn’s disease, and ulcerative colitis. He performs the following procedures: esophagogastroduodenoscopy (a diagnostic endoscopic procedure for the upper digestive tract, also known as EGD), colonoscopy, chromoendoscopy, and video capsule endoscopy.
Dr. Al Bawardy earned his M.D. with distinction from the George Washington University. After medical school, he completed an internal medicine residency, gastroenterology fellowship and a specialized inflammatory bowel disease fellowship at the Mayo Clinic in Rochester, MN, which gave him valuable experience treating the disease alongside leaders in the field.
IBD is a chronic medical condition affecting the gut, and often requires doctors to build long-term relationships with patients to manage their care. This type of medical care was appealing to Dr. Al Bawardy. He is a proponent of shared decision making in management of IBD. When meeting patients, Dr. Al Bawardy discusses risks, benefits, and goals of treatment with his patients so they can make an informed decision about their care. He also asks them about their preferences related to lifestyle and career, for example. He takes all this information into account when developing a treatment plan.
“My patient-care philosophy is that the patient always comes first,” he says.
In addition to caring for IBD patients, Dr. Al Bawardy’s clinical interests include evaluating and treating patients with celiac disease, microscopic colitis and general gastroenterology. Dr. Al Bawardy also conducts research and is an assistant professor of medicine (digestive diseases) at Yale School of Medicine.
Appointments
Digestive Diseases
Assistant Professor AdjunctPrimary
Other Departments & Organizations
- All Institutions
- Digestive Diseases
- Internal Medicine
- Spondyloarthritis Program
- Yale Inflammatory Bowel Disease Center
Education & Training
- IBD Fellow
- Mayo Clinic (2018)
- Fellow
- Mayo Clinic (2017)
- Resident
- Mayo Clinic (2014)
- MD
- The George Washington University (2011)
Research
Copy Link
Overview
Medical Research Interests
ORCID
0000-0002-6102-9267
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Deborah Proctor, MD
Jill Gaidos, MD
Alyssa Ann Grimshaw, MBA, MLIS, MPH
Marie Robert, MD
Kenneth Hung, MD, MS
Louis Levine, MD, MEd
Inflammatory Bowel Diseases
Crohn Disease
Treatment Outcome
Colitis, Ulcerative
Publications
2026
The evolving clinical trial landscape in the MENA region
Quraishi M, Al-Bawardy B. The evolving clinical trial landscape in the MENA region. The Lancet Gastroenterology & Hepatology 2026, 11: 277-278. PMID: 41831455, DOI: 10.1016/s2468-1253(26)00007-5.Peer-Reviewed Original ResearchIncidence of acne in patients with inflammatory bowel disease treated with Janus kinase inhibitors: a systematic review and meta-analysis
Quraishi M, Alahmad M, Swaid T, Facciorusso A, Grimshaw A, Al-Bawardy B. Incidence of acne in patients with inflammatory bowel disease treated with Janus kinase inhibitors: a systematic review and meta-analysis. Inflammatory Bowel Diseases 2026, izag032. PMID: 41784155, DOI: 10.1093/ibd/izag032.Peer-Reviewed Original ResearchAltmetricConceptsIncidence of acnePatients treated with JAK inhibitorsInflammatory bowel diseaseJanus kinase inhibitorsInflammatory bowel disease patientsPooled incidenceRandomized Controlled TrialsAdverse eventsPediatric populationJAK inhibitorsPre-specified subgroup analysesEffective oral therapyInduction phaseJanus kinaseMeta-analysisInflammatory bowel disease populationSystematic reviewInflammatory bowel disease subtypePhase of treatmentOral therapySubgroup analysisKinase inhibitorsClinical subgroupsBowel diseaseRisk factorsAdvanced therapies for inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and meta-analysis
Li D, Chaar A, Arabi T, Quraishi M, Elgamal M, Alahdab F, Grimshaw A, Al-Bawardy B. Advanced therapies for inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and meta-analysis. Inflammatory Bowel Diseases 2026, izag001. PMID: 41677177, DOI: 10.1093/ibd/izag001.Peer-Reviewed Original ResearchConceptsPrimary sclerosing cholangitisInflammatory bowel diseaseIBD-PSCAdvanced therapiesClinical responseAnti-TNFSclerosing cholangitisMeta-analysisConcomitant inflammatory bowel diseaseAnti-tumor necrosis factorEndoscopic remission ratesInflammatory bowel disease associated with primary sclerosing cholangitisRates of overall infectionNon-anti-TNFNon-anti-TNF biologicsSystematic reviewRandom-effects modelClinical remissionEndoscopic remissionAcute cholangitisRemission rateProspective studySubgroup analysisNecrosis factorWeb of ScienceDefinitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study
Cohen N, Bettenworth D, Sror N, Khedraki R, Yang Q, Abreu M, Atreya R, Al-Bawardy B, Connor S, D'Haens G, Dotan I, Dignass A, Ouali S, Feagan B, Feakins R, Gearry R, Gordon I, Hedin C, Hernandez-Rocha C, Kobayashi T, Leibovitzh H, Lu C, Maharshak N, Naseer M, Ollech J, Rubin D, Sebastian S, Siegmund B, Silverberg M, Steinwurz F, Torres J, Watermeyer G, Omprakash T, Frenkel L, Gurizzian P, Silfen A, Tzadok R, Falloon K, Rieder F, Group S. Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study. The Lancet Gastroenterology & Hepatology 2026, 11: 243-255. PMID: 41520669, DOI: 10.1016/s2468-1253(25)00347-4.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsUpper gastrointestinal Crohn's diseaseExpert panelModerated group discussionsAppropriate studiesUpper gastrointestinal involvementClinical practiceGastrointestinal Crohn's diseasePatient representativesInternational expert panelCrohn's diseaseDelphi roundsGastrointestinal involvementSystematic reviewGroup discussionsRoutine clinical practiceDisease locationEndoscopic responseManagement recommendationsImaging severityOutcomesUpper endoscopyHistological outcomesSurgical interventionClinical manifestationsDisease courseP1294 Phenotype, Presentation, and Advanced Therapy Sequencing in Perianal Crohn’s Disease: A Preliminary Analysis from the iGONDOMAR MEA (Middle East and Africa) Cohort
Quraishi M, Ahmed H, Salem O, Maher M, Afifi A, Youssef K, El-Atrebi K, Mogawer M, Alboraie M, Alahmad M, Al-Bawardy B, Sebastian S. P1294 Phenotype, Presentation, and Advanced Therapy Sequencing in Perianal Crohn’s Disease: A Preliminary Analysis from the iGONDOMAR MEA (Middle East and Africa) Cohort. Journal Of Crohn's And Colitis 2026, 20: jjaf231.1475. DOI: 10.1093/ecco-jcc/jjaf231.1475.Peer-Reviewed Original ResearchConceptsPerianal Crohn's diseaseCrohn's diseaseFistula diagnosisAnti-TNFAdvanced therapiesCD diagnosisSpeaker feesManagement of perianal Crohn's diseaseTreatment burdenSecond-line therapyRe-intervention rateMulticenter retrospective studyAnti-TNF therapyConcomitant immunomodulator useNon-TNF biologicsLong-term outcomesSignificant treatment burdenDescriptive analysisDiverting ostomyFistula healingRe-interventionImmunomodulator useMedian ageMontreal classificationRetrospective study
2025
Practical guidelines on medical management of adults with moderate-to-severe inflammatory bowel disease.
Mosli M, Al-Bawardy B, AlAmeel T, Azzam N, Bakkari S, Alharbi O, Almutairdi A, Meeralam Y, Saadah O, Almadi M, Alhazzani W, Alotaibi H, Alenzi K, Al-Omari B, Almudaiheem H, Al-Jedai A. Practical guidelines on medical management of adults with moderate-to-severe inflammatory bowel disease. Saudi Journal Of Gastroenterology 2025 PMID: 41417004, DOI: 10.4103/sjg.sjg_277_25.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseUlcerative colitisCrohn's diseaseAdult patientsAdvanced therapiesMedication management of adultsModerate-to-severe CDBowel diseaseMedical managementTreatment optimization strategiesMaintenance of remissionCombined treatment sequencesManagement of adultsGrading of RecommendationsRisk-benefit analysisEvidence-based careInflammatory disordersAnnual incidenceClinical scenariosEvidence certaintyTreatment sequenceMultidisciplinary panelNational guidelinesEvidence-based approachPICO questionUtilisation and real-world effectiveness of advanced therapies for inflammatory bowel disease in Middle Eastern populations: a systematic review
Quraishi M, Alahmad M, Sharara A, Trivedi P, Al-Bawardy B, Alrubaiy L. Utilisation and real-world effectiveness of advanced therapies for inflammatory bowel disease in Middle Eastern populations: a systematic review. BMJ Open Gastroenterology 2025, 12: e002034. PMID: 41330599, PMCID: PMC12673545, DOI: 10.1136/bmjgast-2025-002034.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsInflammatory bowel diseaseRemission rateCochrane Central RegisterAdvanced therapiesClinical remissionCrohn's diseaseOdds of treatment failureUlcerative colitisBowel diseaseMiddle Eastern populationsControlled TrialsEndoscopic remission ratesBiologic-naive patientsClinical remission rateCochrane Central Register of Controlled TrialsReal-world evidenceCentral Register of Controlled TrialsRegister of Controlled TrialsReal-world effectivenessSaudi studiesMiddle Eastern cohortNewer agentsTreatment failureRandomised controlled trialsStudy designInitial Management of Intra-Abdominal Abscess in Crohn’s Disease: A Systematic Review and Meta-Analysis
Quraishi M, Al Ahmad M, Al Ali N, Church R, Al-Bawardy B. Initial Management of Intra-Abdominal Abscess in Crohn’s Disease: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases 2025, 32: 474-487. PMID: 41211676, DOI: 10.1093/ibd/izaf242.Peer-Reviewed Original ResearchAltmetricConceptsIntra-abdominal abscessComplication of Crohn's diseaseInitial surgeryReoperation rateMedical managementPostinterventional complicationsSurgical interventionManagement of intra-abdominal abscessesCrohn's diseaseSystematic reviewExclusive enteral nutritionLow reoperation rateBridge to surgeryAssociated with significantly lower oddsMeta-analysisAssociated with significantly higher oddsSignificantly higher oddsSignificantly lower oddsRandom-effects modelLength of stayEnteral nutritionSurgery groupDefinitive treatmentSurgical groupSurgical managementPrevalence and Impact of Zinc Deficiency on Clinical Outcomes in Inflammatory Bowel Disease
Almuhaya H, Alsalamah R, Sallam A, Alonazy A, AlAwwad A, Mohamed G, Almutairdi A, Attamimi M, Al-Bawardy B. Prevalence and Impact of Zinc Deficiency on Clinical Outcomes in Inflammatory Bowel Disease. Nutrients 2025, 17: 3378. PMID: 41228451, PMCID: PMC12610508, DOI: 10.3390/nu17213378.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsInflammatory bowel diseaseIBD-related hospitalizationImpact of zinc deficiencyZinc deficiencyRetrospective studyClinical outcomesClinical profileEmergency room visitsMethods:Prevalence of zinc deficiencyClinical profile of patientsBowel diseaseResults:Inflammatory bowel disease patientsZinc-deficient patientsIBD-related surgeryAssociated with higher ratesC-reactive proteinMarkers of inflammationProfile of patientsRoom visitsFecal calprotectinLow albuminInflammatory burdenClinical characteristicsS2001 Assessment of Sociodemographic Factors and Outcomes of Ulcerative Colitis Hospitalizations: A Large Population-Based Study
Sahyoun L, Li D, Al Bawardy B. S2001 Assessment of Sociodemographic Factors and Outcomes of Ulcerative Colitis Hospitalizations: A Large Population-Based Study. The American Journal Of Gastroenterology 2025, 120: s429-s429. DOI: 10.14309/01.ajg.0001135464.36795.f0.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Copy Link
Honors
honor Healthcare Honored Hero
05/01/2021Regional AwardCrohn's and Colitis Foundation, Connecticut/Westchester ChapterDetailsUnited Stateshonor Young Investigator Travel Grant Award
01/01/2020National AwardCrohn's and Colitis FoundationDetailsUnited Stateshonor Howard M. Spiro Fellowship Teaching Award
06/18/2019Yale School of Medicine AwardDigestive Diseases, Yale School of MedicineDetailsUnited Stateshonor Edward C Rosenow Award
05/01/2018Regional AwardDepartment of Internal Medicine. Mayo Clinic, Rochester, MNDetailsUnited Stateshonor Travel Grant Award
12/01/2017National AwardAdvances in Inflammatory Bowel Diseases ConferenceDetailsUnited States
News
Copy Link
News
- August 10, 2023
Ulcerative Colitis: Early Sigmoidoscopy & Clinical Outcomes (Discoveries & Impact August 2023)
- July 13, 2023
Oral Vancomycin as a Treatment Option for Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease (Discoveries & Impact July 2023)
- June 05, 2023
Yale Digestive Diseases Shares Latest Research in Chicago
- April 13, 2023
Discoveries & Impact (April 2023)